TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA August 2, 2013